335 related articles for article (PubMed ID: 33000751)
1. Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET.
Grandone E; Aucella F; Barcellona D; Brunori G; Forneris G; Gresele P; Marietta M; Poli D; Testa S; Tripodi A; Genovesi SC
Blood Transfus; 2020 Nov; 18(6):478-485. PubMed ID: 33000751
[TBL] [Abstract][Full Text] [Related]
2. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
Kimachi M; Furukawa TA; Kimachi K; Goto Y; Fukuma S; Fukuhara S
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011373. PubMed ID: 29105079
[TBL] [Abstract][Full Text] [Related]
3. [Not Available].
Simeon L; Wuillemin WA
Ther Umsch; 2016; 73(10):561-566. PubMed ID: 28045358
[No Abstract] [Full Text] [Related]
4. Position paper on the safety/efficacy profile of Direct Oral Anticoagulants in patients with Chronic Kidney Disease: Consensus document of Società Italiana di Nefrologia (SIN), Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA) and Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET).
Grandone E; Aucella F; Barcellona D; Brunori G; Forneris G; Gresele P; Marietta M; Poli D; Testa S; Tripodi A; Genovesi S
J Nephrol; 2021 Feb; 34(1):31-38. PubMed ID: 32757171
[TBL] [Abstract][Full Text] [Related]
5. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
[TBL] [Abstract][Full Text] [Related]
6. Security profile of direct anticoagulants. Preferred use in atrial fibrillation.
Roldán Rabadán I; Alonso de Leciñana M; Barba Martín R; Páramo Fernández JA;
Clin Investig Arterioscler; 2019; 31(6):263-270. PubMed ID: 31213323
[TBL] [Abstract][Full Text] [Related]
7. [Peri-Interventional Management of Direct Oral Anticoagulants - Balancing Benefits and Risks].
Dülgeroglu J; Schmidt D
Praxis (Bern 1994); 2018 Apr; 107(9-10):485-493. PubMed ID: 29690851
[No Abstract] [Full Text] [Related]
8. [The Multimorbid Patient: Use of New Oral Anticoagulants in Patients with Chronic Kidney Disease].
Mohebbi N
Praxis (Bern 1994); 2018 Jun; 107(13):683-687. PubMed ID: 29921184
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation.
Feldberg J; Patel P; Farrell A; Sivarajahkumar S; Cameron K; Ma J; Battistella M
Nephrol Dial Transplant; 2019 Feb; 34(2):265-277. PubMed ID: 29509922
[TBL] [Abstract][Full Text] [Related]
10. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants.
Ashley J; McArthur E; Bota S; Harel Z; Battistella M; Molnar AO; Jun M; Badve SV; Garg AX; Manuel D; Tanuseputro P; Wells P; Mavrakanas T; Rhodes E; Sood MM
Am J Kidney Dis; 2020 Sep; 76(3):311-320. PubMed ID: 32333946
[TBL] [Abstract][Full Text] [Related]
11. Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies.
Li G; Lip GYH; Holbrook A; Chang Y; Larsen TB; Sun X; Tang J; Mbuagbaw L; Witt DM; Crowther M; Thabane L; Levine MAH
Eur J Epidemiol; 2019 Feb; 34(2):173-190. PubMed ID: 29948370
[TBL] [Abstract][Full Text] [Related]
12. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
Alamneh EA; Chalmers L; Bereznicki LR
Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
[TBL] [Abstract][Full Text] [Related]
13. Modern Treatment Modalities and Duration of Treatment for Venous Thromboembolism.
Robert-Ebadi H; Righini M
Ther Umsch; 2016; 73(10):618-625. PubMed ID: 28045360
[No Abstract] [Full Text] [Related]
14. Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.
Pollack CV
Circulation; 2016 Jan; 133(2):e18-9. PubMed ID: 27028439
[No Abstract] [Full Text] [Related]
15. Renal Function Considerations for Stroke Prevention in Atrial Fibrillation.
Fanikos J; Burnett AE; Mahan CE; Dobesh PP
Am J Med; 2017 Sep; 130(9):1015-1023. PubMed ID: 28502818
[TBL] [Abstract][Full Text] [Related]
16. Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.
Chan KE; Giugliano RP; Patel MR; Abramson S; Jardine M; Zhao S; Perkovic V; Maddux FW; Piccini JP
J Am Coll Cardiol; 2016 Jun; 67(24):2888-99. PubMed ID: 27311528
[TBL] [Abstract][Full Text] [Related]
17. Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review.
Alcocer L
Am J Cardiovasc Drugs; 2016 Jun; 16(3):171-82. PubMed ID: 26923792
[TBL] [Abstract][Full Text] [Related]
18. Jurisdictional Guidance on DOAC Use-Will It Affect Practice? A Comparison of European, American, and Canadian Product Monographs.
Lamb DA; Bungard TJ; Lowerison J; Semchuk WM; Thomson P; Brocklebank C; Bolt J
Ann Pharmacother; 2020 Mar; 54(3):277-282. PubMed ID: 31529984
[No Abstract] [Full Text] [Related]
19. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
Bansal VK; Herzog CA; Sarnak MJ; Choi MJ; Mehta R; Jaar BG; Rocco MV; Kramer H
Am J Kidney Dis; 2017 Dec; 70(6):859-868. PubMed ID: 28941763
[TBL] [Abstract][Full Text] [Related]
20. Bleeding in anticoagulated patients with atrial fibrillation: practical considerations.
Undas A; Drabik L; Potpara T
Pol Arch Intern Med; 2020 Jan; 130(1):47-58. PubMed ID: 31933483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
